Validated GC–MS analysis for the determination of residual fentanyl in applied Durogesic® reservoir and Durogesic® D-Trans® matrix transdermal fentanyl patches - ScienceDirect
Por um escritor misterioso
Descrição
Frontiers Predicting Transdermal Fentanyl Delivery Using Mechanistic Simulations for Tailored Therapy
Development and evaluation of a tampering resistant transdermal fentanyl patch - ScienceDirect
These highlights do not include all the information needed to use FENTANYL TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for FENTANYL TRANSDERMAL SYSTEM. FENTANYL transdermal system CIIInitial U.S. Approval: 1968
Validated GC-MS analysis for the determination of residual fentanyl in applied Durogesic (R) reservoir and Durogesic (R) D-Trans (R) matrix transdermal fentanyl patches
Development and evaluation of a tampering resistant transdermal fentanyl patch - ScienceDirect
Toxicological implications of the delivery of fentanyl from gel extracted from a commercial transdermal reservoir patch - ScienceDirect
FENTANYL TRANSDERMAL SYSTEM 25 mcg/hr, 50 mcg/hr, 75 mcg/hr, 100 mcg/hr CII Full Prescribing Information Rx only FOR USE IN OPIOID-TOLERANT PATIENTS ONLY
Development and evaluation of a tampering resistant transdermal fentanyl patch - ScienceDirect
Validated GC–MS analysis for the determination of residual fentanyl in applied Durogesic® reservoir and Durogesic® D-Trans® matrix transdermal fentanyl patches - ScienceDirect
Development and evaluation of a tampering resistant transdermal fentanyl patch - ScienceDirect
Predicting transdermal fentanyl delivery using mechanistic simulations for tailored therapy
Fentanyl Transdermal Matrix Patch (Durotep® MT Patch; Durogesic® DTrans®; Durogesic® SMAT)
Predicting transdermal fentanyl delivery using mechanistic simulations for tailored therapy
de
por adulto (o preço varia de acordo com o tamanho do grupo)
